NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Feb. 22, 2006--Acacia Research Corporation (Nasdaq:CBMX)(Nasdaq:ACTG) announced today that its CombiMatrix group has launched its Influenza A detection and genotyping technology on the CustomArray(TM) 4X2K platform. This is another step in CombiMatrix's expansion of its product line and another step in CombiMatrix's goal to make Influenza A technology more available and affordable.
